Results 201 to 210 of about 230,861 (252)

Cardiac fibrosis: mechanistic insights and translational advances. [PDF]

Mol Biomed
Xie HY, Zheng XT, Wang XH, Yang JY, Liu YX, Zhao Y, Tang HF, Hu HJ.   +7 more
europepmc   +1 more source

An Update on Selected Giant Cell-Rich Tumors of Soft Tissue. [PDF]

Cancer Genomics Proteomics
Nishio J, Aoki M.
europepmc   +1 more source

<i>FGF18</i> aggravates angiotensin II-induced vascular smooth muscle cell dysfunction via the FGFR-ERK/AKT-GSK3β/β-catenin pathway. [PDF]

J Thorac Dis
He Y, Chen T, Xiang Y, Li D, Zhang H, Wu Z, He Y.   +6 more
europepmc   +1 more source

Activation of the fibroblast growth factor receptor 3 in bladder cancer

, 2007
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibroblast growth factor receptor-3 in urothelial tumorigenesis

Urologic Oncology: Seminars and Original Investigations, 2013
Fibroblast growth factor receptor-3 (FGFR3) is a receptor tyrosine kinase implicated in the tumorigenesis of multiple malignancies, including bladder and other urothelial cancers, multiple myeloma, and cervical cancer. In urothelial carcinoma (UC), constitutive receptor activation occurs most commonly through substitution of a wild-type residue with ...
Gopa, Iyer, Matthew I, Milowsky
openaire   +2 more sources

Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2002
Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been identified in a variety of carcinomas, but there are few studies concerning their presence in oral cancers. The objective of this study was to determine whether FGF-1, FGF-2, and high affinity receptors FGFR2 and FGFR3 are present in the pathogenesis of oral epithelial dysplasias ...
Candice, Wakulich, Linda, Jackson-Boeters, Tom D, Daley, George P, Wysocki   +3 more
openaire   +2 more sources

Mutations of the Fibroblast Growth Factor Receptor-3 Gene in Achondroplasia

Hormone Research, 2008
Achondroplasia (ACH), the most common cause of chondrodysplasia in man (1 in 15,000 live births), is an autosomal dominant condition of unknown origin characterized by short-limbed dwarfism and macrocephaly. Recently, a gene for ACH has been mapped to chromosome 4p16.3.
F, Rousseau, J, Bonaventure, L, Legeai-Mallet, A, Pelet, J M, Rozet, P, Maroteaux, M, Le Merrer, A, Munnich   +7 more
openaire   +2 more sources

Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes

Cell Biology International, 2005
Although fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor 3 (FGFR3) both inhibit longitudinal bone growth, little is known about the relationship between FGF2 and FGFR3. Accordingly, the current study examined the expression of FGFR3 mRNA after the administration of FGF2 using cultured chondrocytes from day 17 chick embryos to ...
Jo-Young, Suh, Young-Sam, Kim, Jin-Woo, Park, Jong-Kyung, Sonn, Woo-Taek, Kim   +4 more
openaire   +2 more sources

Fibroblast growth factor receptor 3 and the human chondrodysplasias

Current Opinion in Pediatrics, 1997
Heterozygous mutations of the gene encoding the fibroblast growth factor receptor 3 (FGFR3) have been found in persons with achondroplasia, thanatophoric dysplasia, and hypochondroplasia. They exhibit considerable genetic homogeneity, and specific mutations strongly correlate with the clinical severity of disease.
openaire   +2 more sources